First-line treatment is with co-trimoxazole, which in severe cases should initially be intravenous. The addition of high-dose corticosteroids in moderate to severe PCP improves outcomes if started within 72 hours of starting specific PCP treatment. In HIV-positive patients co-trimoxazole should be continued for a total of 21 days; in other types of immunosuppression 14 days may be sufficient. Steroids are weaned over 20 days. ART should be started within the first 14 days of PCP treatment in ART-na√Øve, HIV-positive patients.

In resource-limited settings, the diagnosis of PCP is most commonly made on clinical grounds. Differentiating PCP from pulmonary TB is often challenging, and dual infections with both TB and PCP also need to be considered. In the absence of intensive care options severely ill patients may have to be empirically treated for both infections. Co-trimoxazole is often available as an oral formulation only.